---
schema_version: "secwatch.filing_event.v1"
accession: "0001638833-24-000006"
form_type: "8-K"
ticker: "SGRY"
cik: "0001638833"
company_name: "Surgery Partners, Inc."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:21:02.517650+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Surgery Partners reaffirms 2023 guidance, projects 2024 Adj. EBITDA >$495M

## Summary
- Reaffirmed 2023 Adjusted EBITDA guidance of $436M-$440M; revenue ~$2.75B.
- Projected 2024 Adjusted EBITDA greater than $495 million, implying ~13% YoY growth.
- Guidance based on results through November 2023, subject to year-end adjustments.
- Company updated investors at J.P. Morgan Healthcare Conference on January 8, 2024.

## SEC filing metadata
- accession: 0001638833-24-000006
- form_type: 8-K
- ticker: SGRY
- cik: 0001638833
- company_name: Surgery Partners, Inc.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638833/000163883324000006/0001638833-24-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638833/000163883324000006/sgry-20240108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001638833-24-000006
- JSON: https://secwatch.observer/filing/0001638833-24-000006.json
- Plain text: https://secwatch.observer/filing/0001638833-24-000006.txt

## Key facts
- Earnings Releases
  Surgery Partners, Inc. reported 2023 results: revenue approximately $2.75 billion. Guidance reaffirmed.
  - Period: 2023
  - Revenue: approximately $2.75 billion
  - Guidance: reaffirmed
  - Result: guidance update
  source text: Based on results through November 2023, the Company is re-affirming its 2023 Adjusted EBITDA guidance of $436 million to $440 million and its 2023 Revenue guidance of approximately $2.75 billion.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883324000006/0001638833-24-000006-index.htm
- Earnings Releases
  Surgery Partners, Inc. updated its 2024 guidance (initiated).
  - Period: 2024
  - Guidance: initiated
  - Result: guidance update
  source text: In addition, the Company projects 2024 Adjusted EBITDA to be greater than $495 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883324000006/0001638833-24-000006-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.